throbber
Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 1 of 18
`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 1 of 18
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`EXHIBIT 1
`EXHIBIT 1
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 2 of 18
`
`UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`PHILIPS NORTH AMERICA LLC,
`
`v.
`
`FITBIT, INC.,
`
`Plaintiff,
`
`Defendant.
`
`Civil Action No. 1:19-cv-11586-IT
`
`PHILIPS NORTH AMERICA LLC’S NOTICE OF
`DEPOSOTION TO DEFENDANT FITBIT, INC.
`
`TO ALL PARTIES AND THEIR ATTORNEYS OF RECORD:
`
`PLEASE TAKE NOTICE that pursuant to Rule 30 of the Federal Rules of Civil
`
`Procedure, Plaintiff Philips North America LLC (“Philips”) through its attorneys of record, will
`
`take the deposition of Fitbit, Inc. (“Defendant”), concerning the Topics set forth in Appendix A.
`
`The deposition will commence at a mutually agreeable date and time at the offices of
`
`Philips’s counsel, Foley & Lardner LLP, or at such other place as has been mutually agreed by
`
`the parties. For purposes of this Notice, Philips proposes September 14, 2020.
`
`Pursuant to Federal Rule of Civil Procedure 30, the deposition will be taken before an
`
`authorized court reporter and will be videotaped.
`
`Defendant shall designate one or more officers, directors, managing agents, or other
`
`persons who consent to testify on their behalf with respect to what is known or is reasonably
`
`available to Defendant concerning each of the topics of examination set forth in Appendix A
`
`attached hereto. For each person designated, Defendant shall advise Philips of the identity of that
`
`person and the topic(s) on which that person shall testify at least five (5) business days in
`
`advance of the deposition.
`
`
`
`

`

`
`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 3 of 18
`
`
`PHILIPS NORTH AMERICA LLC,
`
`Dated, August 24, 2020
`
`By Its Attorneys,
`
`/s/ Ruben J. Rodrigues
`Ruben Rodrigues (BBO 676,573)
`Lucas I. Silva (BBO 673,935)
`John Custer (BBO 705,258)
`FOLEY & LARDNER LLP
`111 Huntington Avenue
`Suite 2500
`Boston, MA 02199-7610
`Phone: (617) 342-4000
`Fax: (617) 342-4001
`rrodrigues@foley.com
`lsilva@foley.com
`jcuster@foley.com
`
`
`Eley O. Thompson (pro hac vice)
`FOLEY & LARDNER LLP
`321 N. Clark Street
`Suite 2800
`Chicago, IL 60654-5313
`Phone: (312) 832-4359
`Fax: (312) 832-4700
`ethompson@foley.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 4 of 18
`
`APPENDIX A
`INSTRUCTIONS
`You are to prepare fully and completely to testify regarding the
`1.
`following Topics for Examination after conducting a diligent and thorough
`investigation into all information within Your possession, custody, or control. If
`You cannot fully and completely testify regarding any Topic, You are to prepare to
`testify regarding the Topic to the extent possible, specify the portion of the Topic
`You are unable to prepare for, and provide any information You have regarding
`that portion.
`If any Topic seeks testimony referencing or regarding a document or
`2.
`thing that has been lost, discarded, destroyed, or is otherwise unavailable for any
`reason, You should prepare to testify as to: the pertinent information contained in
`the document, the date of disposal, the manner of disposal, the reason for disposal,
`any person, firm or corporation who has possession, custody, or control of a full,
`partial, or incomplete copy of such document, and the identity of all persons who
`participated in the destruction or discarding or who have knowledge of the data and
`circumstances surrounding the destruction or discarding of the document or thing.
`3.
`If any Topic is objected to in part, You should prepare to testify
`regarding all portions of the Topic not objected to.
`4.
`If You claim that a Topic is overbroad and/or unduly burdensome,
`identify the respect in which the Topic is allegedly overbroad and/or unduly
`burdensome, and prepare to testify regarding any unobjectionable portion of the
`Topic.
`If You claim that a Topic is vague or ambiguous, identify the
`5.
`particular words, terms or phrases that You contend make the Topic vague and/or
`ambiguous, and specify the meaning You attribute to those words, terms, or
`phrases for purposes of Your testimony pertaining thereto.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 5 of 18
`
`These Topics shall include information acquired or identified up to the
`6.
`deposition and shall be deemed to be continuing. Therefore, You shall promptly
`supplement Your deposition testimony with any additional information that You
`identify, acquire, or become aware of up to and including the time of hearing.
`DEFINITIONS
`The following definitions apply to the Topics set forth below and to the
`other definitions and instructions provided.
`1.
`“Fitbit,” “You,” and “Your” mean Fitbit, Inc. and any present or
`former parent, subsidiary, department, division, subdivision, branch, affiliate,
`predecessor, successor-in-interest, or other related company, and includes any
`present or former officer, director, agent, employee, consultant, counsel, or
`representative of Fitbit, and any other person acting on or purporting to act on their
`behalf, including outside counsel or patent agents.
`2.
`The “’007 Patent” means U.S. Patent No. 6,013,007.
`3.
`The “’233 Patent” means U.S. Patent No. 7,088,233.
`4.
`The “’377 Patent” means U.S. Patent No. 8,277,377.
`5.
`“Asserted Patent(s)” mean the ’007 Patent, the ’233 Patent, and the
`’377 Patent.
`“Accused Products” means any of the activity tracker products offered
`6.
`by Fitbit that were identified in Philips’s L.R. 16.6 Disclosures, as well as any
`software products related to, associated with, or used in conjunction with said
`activity tracker products (regardless of whether such software runs on the activity
`tracker itself, a mobile device, desktop/laptop computer, server, or other computing
`device), including but not limited to the Fitbit App and the Fitbit.com Dashboard.
`7.
`“Communication” means any transmission of information from one
`person to another, regardless of the medium, and includes, without limitation, oral,
`electronic and written transmissions of information.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 6 of 18
`
`“Date” means the precise day, month, and year, if known, or as
`8.
`precise a statement of the day, month, and year as is permitted by Your knowledge
`and the information available to You.
`9.
`“Document” or “documents” has the meaning prescribed in Federal
`Rule of Civil Procedure 34 and Federal Rule of Evidence 1001. The term
`“document” includes documents in any form, including documents stored
`electronically. Any comment or notation appearing on any document, and not part
`of the original text, is to be considered a separate “document.”
`10.
`“Person” means any natural person, individual, firm, corporation,
`partnership, proprietorship, joint venture, unincorporated associations, government
`agency, and all other groups of persons, organizations, or entities of any type.
`11.
`“Thing” has the meaning prescribed in Federal Rule of Civil
`Procedure 34. “Thing” specifically includes, without limitation, any disc, tape, or
`other electronic media storage device, any product, and any model, prototype, or
`experimental device or part or subassembly thereof.
`12. To “identify” a product means to provide the manufacturer and
`distributor of the product and all applicable designations including, without
`limitation, the product number, model number, product designations, trademarks,
`and trade names used in the industry, and if there are multiple versions of the
`product, the version number or designation of each version.
`13. To “identify” a communication means to provide the date of the
`communication, the identity of the person who initiated the communication, the
`identity of each person who received such communication (including any cc or bcc
`recipients), the form of the communication, and a general description of the
`content of the communication.
`14. To “identify” a document means to provide the date of preparation and,
`if different, the date of the document itself, the identity of each author, the identity
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 7 of 18
`
`of each addressee and copy recipient, the format of the document (e.g., hardcopy or
`electronic), the number of pages and the type of document, and the present location
`and the identity of each person who has possession, custody or control of the
`document, and the production number of such document.
`15. To “identify” a person means to provide the person’s full name,
`present or last known residence address and telephone number, present or last
`known employer or other business affiliation, and the person’s present or last
`known employment address and telephone number.
`16. To “identify” an entity means to provide its full name, present or last
`known address, date and location of incorporation or organization, the name under
`which it was organized, the name of the chief executive officer or person holding a
`comparable position, and the identity of all natural persons within the entity having
`knowledge of the subject matter with respect to which the entity is being identified
`in response to an interrogatory.
`17. The phrases “relate(s) to,” “relating to,” “refer(s) to,” “referring to,”
`“regard(s),” “regarding,” “concern(s),” and “concerning” mean embodying,
`identifying, confirming, containing, showing, or pertaining to in any way, directly
`or indirectly, or having any logical or factual connection with the subject matter in
`question.
`18. The terms “and,” “or,” and “and/or” shall be construed in the
`conjunctive and the disjunctive.
`19. The singular shall be construed to include the plural and vice versa.
`
`DEPOSITION TOPICS
`The factual bases concerning Your contention that each Accused
`1.
`Product does not infringe the ’007 Patent, including whether:
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 8 of 18
`
`(a)
`
`(b)
`
`(b)
`
`(b)
`
` each Accused Product infringes by direct infringement,
`induced infringement, and/or contributory infringement; and
`each limitation is present literally or under the Doctrine of
`Equivalents in each Accused Product.
`The factual bases concerning Your contention that each Accused
`2.
`Product does not infringe the ’233 Patent, including whether:
`(a)
` each Accused Product infringes by direct infringement,
`induced infringement, and/or contributory infringement; and
`each limitation is present literally or under the Doctrine of
`Equivalents in each Accused Product.
`The factual bases concerning Your contention that each Accused
`3.
`Product does not infringe the ’377 Patent, including whether:
`(a)
` each Accused Product infringes by direct infringement,
`induced infringement, and/or contributory infringement; and
`each limitation is present literally or under the Doctrine of
`Equivalents in each Accused Product.
` Your policies and procedures for generating, maintaining, and
`4.
`disposing of records.
`5.
`The facts and circumstances surrounding any investigations, analyses,
`or efforts relating to any attempts to, plans to, and/or analyses of ways to design
`around any claim of any of the Asserted Patents, and the results of such
`investigations, analyses, or efforts, including whether and why any design-around
`alternative was incorporated into any Accused Product.
`6.
`The facts and circumstances surrounding any business decisions made
`by Fitbit and/or other actions taken in response to learning of any of the Asserted
`Patents and other patents claiming overlapping priority, and/or the filing of this
`Action.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 9 of 18
`
`The facts and circumstances surrounding any communication between
`7.
`You and any person concerning Philips or any of the Asserted Patents and other
`patents claiming overlapping priority.
`8.
`The marketing and sales of each of the Accused Products including,
`but not limited to:
`For each Accused Product: the sales, offers for sale, gross and
`
`a.
`net revenues, costs of goods sold, gross and net profits, expenses, and any
`discounts for each Accused Product, broken down by year and month,
`from the time period of the introduction of each Accused Product to
`present.
`Your annual budgets, financial projections and forecasts
`b.
`relating to revenues, costs, sales volumes and profits for the Accused
`Products, from the time period of the introduction of each Accused
`Product to present.
`c.
`The profitability and expected profitability of each Accused
`Product.
`Your decision to market, sell, license, distribute, promote,
`d.
`and/or offer to sell each Accused Product.
`e.
`Your pricing strategies, policies and procedures for each
`Accused Product.
`
`f.
`All sales, marketing and/or business plans, market segments,
`predictions concerning the past, present, or future size of the market,
`competitors, and market share, development of strategies for marketing
`for each Accused Product.
`g.
`Your strategy to differentiate each of the Accused Products
`from competitors’ products.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 10 of 18
`
`Your marketing efforts and materials related to the benefits,
`h.
`drawbacks, value, and/or importance of each Accused Product.
` Fitbit’s organizational structure for the following areas: engineering,
`9.
`
`design, and research and development; manufacture, fabrication, and assembly;
`and marketing, sales, and promotion.
`10. The facts and circumstances surrounding any claim for
`indemnification or potential indemnification Fitbit has made or will make relating
`to this Action, including the entity from which indemnification was, is, or will be
`sought or to which indemnification was, is, or will be given.
`11. The facts and circumstances surrounding any communications relating
`to this Action between Fitbit and any third party involved in the design,
`development, manufacture, distribution, or importation of each of the Accused
`Products since Philips’s filing of the Complaint in this Action, including
`communications relating to the allegations made in this Action and any effect this
`Action might have on Fitbit’s continued manufacture and sale of the Accused
`Products.
`12. The factual bases for Your contention that any of the Asserted Patents
`are invalid under any subsection of 35 U.S.C. §§ 101, 102, 103, and/or 112.
`13. The factual bases for Your assertion that Fitbit is “entitled to its
`attorney’s fees and costs under 35 U.S.C. 285 and Rule 11.”
`14. The factual bases concerning the secondary considerations of non-
`obviousness of the Asserted Patents.
`
`15. The facts and circumstances concerning when Fitbit first became
`aware of the Asserted Patents or any other patents claiming overlapping priority to
`the Asserted Patents, including the individuals involved and the original source of
`information from which Fitbit learned of them.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 11 of 18
`
`16. Knowledge by people developing the Accused Products of
`competitive or related products, including reference to such products and review of
`technical information relating to such products.
`17. Fitbit’s policies with regards to determining whether or not any of its
`products, including the Accused Products, practice the patents of other or infringe
`upon the intellectual property of others, including patent searches, and
`communications related to such efforts.
`18. Fitbit’s efforts to stay apprised of intellectual property that might
`relate to its products and services.
`19. Fitbit’s efforts to clear each of the Accused Products of potential
`patent infringement, including patent searches, and communications related to such
`efforts in regards to the Asserted Patents or other patents claiming overlapping
`priority.
`20. Fitbit’s refusal to take a royalty-bearing license under the Patents-in-
`
`Suit.
`
`21. Fitbit’s implementation of GPS functionality in each of the Accused
`Products.
`22. For each of the Accused Products that include GPS functionality, the
`operation of such functionality including any calculated outputs derived from GPS
`waypoints as well as the methods by which the Accused Products (including any
`Fitbit app or server) calculate those outputs.
`23. For each of the Accused Products that include or utilize the Fitbit App
`or Fitbit.com Dashboard, the operation and functionality of the Fitbit App or
`Fitbit.com Dashboard, including but not limited to:
`
`a. The transfer of data between each of the Accused Products and the
`Fitbit App or website including the identity of the data transferred,
`the frequency that said data is transferred, the form in which said
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 12 of 18
`
`data is transferred, the medium(s) used in the transfer of said data,
`and the authentication of said data.
`b. The transfer of data between the Fitbit App or Fitbit.com
`Dashboard and Fitbit’s servers including the identity of the data
`transferred, the frequency of said data transfers, the form in which
`said data is transferred, the medium(s) used in the transfer of said
`data, and the authentication of said data.
`c. The calculations of any outputs that are displayed on the Accused
`Devices, the Fitbit App, or Fitbit.com Dashboard including the
`inputs used in such calculations and the location where such
`calculations take place, including but not limited to the following
`outputs:
`i. Distance
`ii. Location and/or route displayed on a map
`iii. Calories burned
`iv. Average Pace
`v. Split Pace
`vi. Speed
`vii. Heart rate
`viii. Active Minutes
`ix. Cardio Fitness Level
`x. Cardio Fitness Score
`xi. Minutes in Heart Rate Zones
`xii. Sleep Stages
`xiii. Sleep Score
`d. The pairing of the Fitbit App with the Accused Products.
`e. How the Fitbit App is downloaded to users’ devices such as
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 13 of 18
`
`phones or tablets.
`f. Login features for accounts on the Fitbit App or Fitbit.com
`Dashboard.
`g. The user interface on the Fitbit App.
`h. The Exercise Sharing feature of the Fitbit App. See, e.g., PNA-
`FB0000132
`i. The sharing of maps and/or routes on the Fitbit App. See, e.g.,
`PNA-FB0000909.
`j. The calculation and display of the comparison of data between
`different users. See, e.g., Philips L.R. 16.6(d)(1) Disclosures, First
`Supplemental Ex. 1, at 24-27, 30-35
`k. The “Fitbit Coach” feature. See PNA-FB0002449; PNA-
`FB0002459.
`l. The display of advertising messages on the Fitbit App and/or the
`Fitbit.com Dashboard.
`24. For each Accused Product that includes GPS functionality, the
`functionality of the “Voice Cues” feature. See PNA-FB0000905.
`25. The method and functionality of how the Fitbit Ionic is paired with
`Bluetooth headphones, speakers or other audio devices. See PNA-FB0000204.
`26. For each Accused Product that includes GPS functionality, the
`functionality of the “Auto-Pause” feature. See PNA-FB0000188; PNA-
`FB0002454-2455.
`27. For each Accused Product that includes GPS functionality, the
`functionality of the “Run Detect” feature. See PNA-FB0000188.
`28. For each Accused Product that includes GPS functionality, the
`functionality of the “SmartTrack” feature. See PNA-FB0002365.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 14 of 18
`
`29. Your receipt of the October 10, 2016 letter from Elias Schilowitz
`addressed to Fitbit, Inc. and Mr. Park specifically (produced as PNA-FB0003515-
`17), which identified each of the Asserted Patents, including any actions You took
`in response to receiving the letter.
`30. Your receipt of the March 23, 2017 letter from Elias Schilowitz
`addressed to Fitbit, Inc. and Mr. Park specifically (produced as PNA-FB0003498-
`501), which enclosed the October 10, 2016 letter (produces as PNA-FB0003515-
`17), which identified each of the Asserted Patents, including any actions You took
`in response to receiving the letter.
` 31. Your receipt of the April 13, 2017 letter from Elias Schilowitz
`addressed to Fitbit, Inc. and Mr. Park specifically (produced as PNA-FB0003502-
`509), which enclosed the October 10, 2016 letter (produced as PNA-FB0003515-
`17) and the March 23, 2017 letter (produced as PNA-FB0003498-501), which
`identified each of the Asserted Patents, including any actions You took in response
`to receiving the letter.
`32. Your earliest notice of the ’007 patent.
`33. Your earliest notice of the ’233 patent.
`34. Your earliest notice of the ’377 patent.
`35. The gathering and production of documents, things and any other
`information responsive to any discovery request propounded by Philips in this
`Action.
`36. Any agreements or conversations between and/or among Fitbit and/or
`any third party regarding this Action or any litigation with Philips.
`37. Fitbit’s document retention, management, and/or destruction policies.
`38. All activities undertaken by or for Fitbit to preserve, locate, identify,
`collect, and produce discoverable documents (including tangible things,
`electronically stored data and information) relevant to this Action.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 15 of 18
`
`39. All documents destroyed, lost or otherwise no longer available, that
`relate to the ’007 Patent, including the current or former existence of said
`documents.
` All documents destroyed, lost or otherwise no longer available, that
`40.
`relate to the ’233 Patent, including the current or former existence of said
`documents.
` All documents destroyed, lost or otherwise no longer available, that
`41.
`relate to the ’377 Patent, including the current or former existence of said
`documents.
`42. All factual bases for Your contention, if any, that any relief sought by
`Philips for infringement of the Asserted Patents is barred in whole or in part by
`virtue of waiver and/or estoppel.
`43. All factual bases for Your contention, if any, that one or more of the
`Asserted Patents is unenforceable to the extent that the alleged inventors did not
`invent the claimed inventions or to the extent that the actual inventors are not
`named as inventors.
`44. The relevant market(s) for each Accused Product, including a
`description of the market, the competitors, and the market share of those
`competitors.
`45. All marketing and advertising of each Accused Product.
`46. All factual bases for Your contention, if any, that any relief sought by
`Philips is barred in whole or in part by any alleged license and/or covenant not to
`sue granted under the Asserted patents and/or by patent exhaustion.
`47. All factual bases for Your contentions that any Asserted Patent is
`invalid due to anticipation, obviousness, lack of written description, lack of
`enablement, indefiniteness, and/or being directed to unpatentable subject matter.
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 16 of 18
`
`48. All factual bases for Your contention, if any, that any Asserted Patent
`is unenforceable due to inequitable conduct.
`49. All written opinions of counsel regarding the Asserted Patents and all
`communications relating to said opinions.
`50. The scope and content of prior art to the Asserted Patents.
`51. The relationship between Philips and Fitbit, including
`communications between Philips and Fitbit with regard to the Asserted Patents.
`52. Any alleged non-infringing alternatives to the Asserted Patents,
`including the identity of each alternative, the time period during which each
`alternative was available, the time and cost to develop, design, and manufacture
`each alternative, and any differences between each alternative and the Accused
`Products.
`53. The factual basis for any contention by Fitbit that its infringement of
`the Asserted Patents, if proven, is in good faith and not willful.
`54. The identity and terms of any patent license to which Fitbit is a party.
`55. Price trends, sales trends, market growth (or contraction), barriers to
`entry, and elasticity relating to the Accused Products.
`56. All surveys, market research, market analyses, market evaluations,
`and forecasts concerning or related to the Accused Products.
`57. Communications with Fitbit’s customers regarding the Accused
`Products, including instructions, training, and any other communications regarding
`the deployments and operation of the Accused Products.
`58. The marketing and sales of products or services sold as accessories to,
`in conjunction with, at the same time as, or otherwise relating to the sales
`identified above, including for all such accessory products or services the numbers
`for each of the metrics requested above, the manner by which each of these
`numbers was calculated, the methodology employed in such calculation, and the
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 17 of 18
`
`documents reviewed, relied upon, or prepared in connection with calculating such
`numbers.
`59. Fitbit’s financial statements.
`
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 319-1 Filed 02/23/22 Page 18 of 18
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the above document was
`
`served on August 24, 2020 on counsel for Defendant via electronic mail.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /s/ John W. Custer
`
`
`
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket